Oncological Dispensary No. 2
- Research works
- 51 ▲ 59% vs 2013–17
- Citations
- 101 2.0 per fractional work
- Top-10% rate
- 0.2% record average 16.5%
- Open access
- 67% world 28%
Not ranked overall: Oncological Dispensary No. 2 is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Medicine, 3.6×. Every wedge is a field page.
Which keywords describe research at Oncological Dispensary No. 2?
By fractional works in all years, weighted toward what it does more of than the world: Chemotherapy, Clinical Practice Guidelines, Breast Cancer, Survival Analysis, Immunotherapy, Metastatic Breast Cancer, Neoadjuvant Therapy and Clinical Trials.
- Total Mesorectal Excision
- Mortality Trends
- Treatment Response
- Molecular Subtypes
- Adjuvant Chemotherapy
- Robotic Surgery
- Melanoma
- Tumor Markers
- Radiation Therapy
- Laparoscopic Surgery
- Prevention
- Prognostic Factors
- Cancer
- Radiotherapy
- Palbociclib
- Metastasis
- Neoadjuvant Therapy
- Immunotherapy
- Breast Cancer
- Clinical Practice Guidelines
- Chemotherapy
- Epidemiology
- Survival Analysis
- Metastatic Breast Cancer
- Clinical Trials
- CDK4/6 Inhibitors
- Biomarkers
- Risk Factors
- Quality of Life
- Sentinel Lymph Node Biopsy
- Gene Expression
- Prognostic Markers
- Tumor Microenvironment
- Genetic Mutations
- Photodynamic Therapy
- Urothelial Carcinoma
- Breast Tumours
- Preoperative Chemoradiotherapy
- Cardiovascular Diseases
- Rectal Cancer
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Chemotherapy5▲ 14×14 topics
- Clinical Practice Guidelines5▲ 16×7 topics
- Epidemiology4▲ 2.2×20 topics
- Breast Cancer4▲ 30×6 topics
- Survival Analysis4▲ 25×4 topics
- Immunotherapy3▲ 10×10 topics
- Metastatic Breast Cancer3▲ 101×2 topics
- Neoadjuvant Therapy3▲ 30×5 topics
- Clinical Trials3▲ 9.8×5 topics
- Metastasis3▲ 16×7 topics
- CDK4/6 Inhibitors3▲ 320×1 topic
- Palbociclib3▲ 320×1 topic
- Biomarkers2▲ 7.7×7 topics
- Radiotherapy2▲ 12×4 topics
- Risk Factors2▲ 4.4×6 topics
- Cancer2▲ 3.0×14 topics
- Quality of Life2▲ 3.2×9 topics
- Prognostic Factors2▲ 8.7×9 topics
- Sentinel Lymph Node Biopsy2▲ 55×2 topics
- Prevention2▲ 9.0×2 topics
- Gene Expression2▲ 5.4×4 topics
- Laparoscopic Surgery2▲ 30×2 topics
- Prognostic Markers2▲ 35×2 topics
- Radiation Therapy2▲ 22×3 topics
- Tumor Microenvironment2▲ 9.2×5 topics
- Tumor Markers2▲ 43×2 topics
- Genetic Mutations2▲ 5.8×5 topics
- Melanoma2▲ 58×2 topics
- Photodynamic Therapy2▲ 18×3 topics
- Robotic Surgery2▲ 21×2 topics
- Urothelial Carcinoma2▲ 67×2 topics
- Adjuvant Chemotherapy1▲ 37×2 topics
- Breast Tumours1▲ 54×1 topic
- Molecular Subtypes1▲ 32×2 topics
- Preoperative Chemoradiotherapy1▲ 38×2 topics
- Treatment Response1▲ 54×1 topic
- Cardiovascular Diseases1▲ 22×1 topic
- Mortality Trends1▲ 99×1 topic
- Rectal Cancer1▲ 72×1 topic
- Total Mesorectal Excision1▲ 72×1 topic
Which research topics does Oncological Dispensary No. 2 publish most on?
By volume in 2022–2025: Advanced Breast Cancer Therapies, Endometrial and Cervical Cancer Treatments, Breast Cancer Treatment Studies and HER2/EGFR in Cancer Research.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 2 works
- 2 Endometrial and Cervical Cancer Treatments Obstetrics and Gynecology 1 works
- 3 Breast Cancer Treatment Studies Cancer Research 1 works
- 4 HER2/EGFR in Cancer Research Oncology 1 works
- 5 Cancer-related molecular mechanisms research Cancer Research 1 works
- 6 Cancer Immunotherapy and Biomarkers Oncology 1 works
- 7 Chemotherapy-induced cardiotoxicity and mitigation Cardiology and Cardiovascular Medicine 0 works
- 8 Chronic Myeloid Leukemia Treatments Hematology 0 works
- 9 Cancer Treatment and Pharmacology Oncology 0 works
- 10 Cutaneous Melanoma Detection and Management Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Oncological Dispensary No. 2's research output changed?
Output in 2018–2022 was 59% higher than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Krasnodar
- Kuban State University
- Kuban State Agrarian University
- Kuban State Medical University
- Kuban State Technological University
- North-Caucasian Zonal Research Institute of Horticulture and Viticulture
- Krasnodar University of Ministry of Internal Affairs of Russia
- All-Russian Research Institute of Oil Crops by V.S. Pustovoit
- Krasnodar Research Institute of Storage and Processing of Agricultural Products
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.